This masterclass provides clinicians with a practical, clinically relevant framework for understanding and prescribing GLP-1 therapies while addressing the full spectrum of obesity medicine treatment. Participants will gain a clear understanding of metabolic disease pathophysiology, appropriate clinical workup, medication selection and sequencing—including all FDA-approved anti-obesity medications—as well as nutrition optimization, cognitive-behavioral strategies, and lifestyle interventions that support sustainable metabolic outcomes.